Passie, Torsten

Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases

Gasser, P., Holstein, D., Michel, Y., Doblin, R., Yazar-Klosinski, B., Passie, T., & Brenneisen, R. (2014) · Journal of Nervous & Mental Disease

Psychedelics and Drug StudiesMusic Therapy and Health

Cited by 750

The pharmacology of psilocybin

Passie, T., Seifert, J., Schneider, U., & Emrich, H. M. (2002) · Addiction Biology

Psychedelics and Drug StudiesForensic Toxicology and Drug Analysis

Cited by 465

LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects

Gasser, P., Kirchner, K., & Passie, T. (2015) · Journal of Psychopharmacology

Psychedelics and Drug StudiesReligion, Spirituality, and Psychology

Cited by 456

The pharmacology of lysergic acid diethylamide: A review

Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008) · CNS Neuroscience & Therapeutics

Psychedelics and Drug StudiesNeurotransmitter Receptor Influence on Behavior

Cited by 455

Reviewing the Potential of Psychedelics for the Treatment of PTSD

Krediet, E., Bostoen, T., Breeksema, J., van Schagen, A., Passie, T., & Vermetten, E. (2020) · International Journal of Neuropsychopharmacology

Psychedelics and Drug StudiesPosttraumatic Stress Disorder Research

Cited by 260

A review of hallucinogen persisting perception disorder (HPPD) and an exploratory study of subjects claiming symptoms of HPPD.

Halpern, J. H., Lerner, A. G., & Passie, T. (2016) · Current Topics in Behavioral Neurosciences

Psychedelics and Drug StudiesHallucinations in medical conditions

Cited by 133

Mitigation of post‐traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence

Passie, T., Emrich, H. M., Karst, M., Brandt, S. D., & Halpern, J. H. (2012) · Drug Testing and Analysis

Cannabis and Cannabinoid ResearchPosttraumatic Stress Disorder Research

Cited by 117

The early use of MDMA (‘Ecstasy') in Psychotherapy (1977–1985)

Passie, T. (2018) · Drug Science Policy and Law

Psychedelics and Drug StudiesHistorical Psychiatry and Medical Practices

Cited by 116

The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series

Karst, M., Halpern, J. H., Bernateck, M., & Passie, T. (2010) · Cephalalgia

Migraine and Headache StudiesPsychedelics and Drug Studies

Cited by 106

Lower-dose psycholytic therapy – A neglected approach

Passie, T., Guss, J., & Krähenmann, R. (2022) · Frontiers in Psychiatry

Psychedelics and Drug StudiesPsychotherapy Techniques and Applications

Cited by 81

Ecstasy (MDMA) mimics the post-orgasmic state: impairment of sexual drive and function during acute MDMA-effects may be due to increased prolactin secretion

Passie, T., Hartmann, U., Schneider, U., Emrich, H. M., & Krüger, T. H. C. (2005) · Medical Hypotheses

Psychedelics and Drug StudiesSexual function and dysfunction studies

Cited by 71

A phenomenology of subjectively relevant experiences induced by ayahuasca in upper Amazon vegetalismo tourism

Wolff, T. J., Ruffell, S., Netzband, N., & Passie, T. (2019) · Journal of Psychedelic Studies

Psychedelics and Drug StudiesParanormal Experiences and Beliefs

Cited by 40

Response to Tfelt-Hansen P: Is BOL-148 hallucinogenic?

Karst, M., Halpern, J., Bernateck, M., & Passie, T. (2011) · Cephalalgia

Migraine and Headache StudiesHallucinations in medical conditions

Cited by 4